Thoratec Corporation · Pleasanton, CA United States · (NASDAQ (GS): THOR)
Company Description
- S&P 400
This link will open in a new window Suffering from a broken heart? Thoratec's there for the rebound. The company makes ventricular assist devices (VAD) for patients suffering late-stage heart failure, including those awaiting a heart transplant. Thoratec offers external and implantable products that provide circulatory support for both acute and long-term needs. The company's International Technidyne Corporation (ITC) subsidiary sells blood coagulation diagnostic equipment and skin incision devices used for drawing blood. Thoratec also sells Vectra, a graft used in renal hemodialysis. The company works closely with hospitals and cardiac surgery centers primarily in the US and Europe. Its incision products are sold worldwide through distributors. To read the full description, subscribe now.
Thoratec Corporation Reports
Download presentation-ready reports for this company now.
Key Thoratec Corporation Financials
| Company Type | Public - NASDAQ (GS): THOR Headquarters |
| Fiscal Year-End | December |
| 2009 Employees | 1,258 |
Thoratec Corporation Executives
| Title | Name & Bio | Contact |
| Chairman | Neil Dimick | |
| President, CEO, and Director | Gerhard Burbach | |
| EVP and CFO | David Smith |